GlassScriptPhysician profile
Pierre R Tibi
NPI 1811926660
$76,950.34
in general payments reported to CMS, 2019-2025
31 companies · $9,439 in 2025
The $9,439 reported for 2025 was more than what 89% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $2,084 · 2021: $2,675 · 2022: $8,933 · 2023: $1,396 · 2024: $41K · 2025: $9,439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $19K · Consulting Fee: $16K · Honoraria: $6,211 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,110 · Education: $3,345 · Food and Beverage: $1,875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $19,012.44 |
| Consulting Fee | $16,188.50 |
| Honoraria | $6,210.80 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,110.00 |
| Education | $3,345.00 |
| Food and Beverage | $1,875.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $14,672.52 | 2024 | Kcentra |
| Baxter Healthcare | $12,291.81 | 2019-2024 | Floseal, Tisseel |
| Pharmacosmos Therapeutics INC. | $12,211.09 | 2024 | Monoferric |
| Hemosonics LLC | $10,644.58 | 2020-2024 | Quantra Qplus System, Qunatra Qplus System |
| American Regent | $10,301.00 | 2019 | |
| Grifols Shared Services North America, INC. | $8,974.61 | 2025 | |
| Vifor (International) LTD. | $2,901.00 | 2024 | |
| Edwards Lifesciences Corporation | $2,623.62 | 2019-2025 | Mitris Resilia Mitral Valve |
| Artivion, INC. | $405.20 | 2019-2024 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $333.41 | 2019-2025 | Lifevest |
| Livanova USA, INC. | $288.14 | 2019-2021 | |
| Medtronic, INC. | $258.43 | 2021-2024 | Penditure |
| Becton, Dickinson and Company | $134.30 | 2019-2025 | Hemosphere |
| Medtronic Vascular, INC. | $124.24 | 2019-2020 | |
| Haemonetics Corporation | $90.36 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Werfen USA LLC | $87.22 | 2023 | |
| Elutia, INC. | $87.14 | 2020 | |
| Atricure, INC. | $70.51 | 2019-2022 | |
| Abbott Laboratories | $69.46 | 2019 | |
| Masimo Corporation | $49.74 | 2021 | |
| Clearflow INC. | $48.48 | 2024 | Pleuraflow System With Flowglide |
| Abiomed | $44.19 | 2020 | |
| Ethicon US, LLC | $41.83 | 2023-2024 | Vistaseal, Surgiflo Hemostatic Matrix, Stratafix |
| Intuitive Surgical, INC. | $34.59 | 2020 | |
| Amgen INC. | $33.47 | 2019 | |
| La Jolla Pharmaceutical Company | $31.93 | 2025 | Giapreza |
| Boston Scientific Corporation | $26.05 | 2019 | |
| Medistim USA, INC. | $20.74 | 2019 | |
| Janssen Pharmaceuticals, INC | $19.98 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $18.77 | 2019 | |
| Chiesi USA, INC. | $11.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pierre Tibi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.